Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1987 Aug;84(16):5991–5994. doi: 10.1073/pnas.84.16.5991

Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease.

S G van Duinen, E M Castaño, F Prelli, G T Bots, W Luyendijk, B Frangione
PMCID: PMC298989  PMID: 3475718

Abstract

Hereditary cerebral hemorrhage with amyloidosis in Dutch patients is an autosomal dominant form of vascular amyloidosis restricted to the leptomeninges and cerebral cortex. Clinically the disease is characterized by cerebral hemorrhages leading to an early death. Immunohistochemical studies of five patients revealed that the vascular amyloid deposits reacted intensely with an antiserum raised against a synthetic peptide homologous to the Alzheimer disease-related beta-protein. Silver stain-positive, "senile plaque-like" structures were also labeled by the antiserum, yet these lesions lacked the dense amyloid cores present in typical plaques of Alzheimer disease. No neurofibrillary tangles were present. Amyloid fibrils were purified from the leptomeningeal vessels of one patient who clinically had no signs of dementia. The protein had a molecular weight of approximately equal to 4000 and its partial amino acid sequence to position 21 showed homology to the beta-protein of Alzheimer disease and Down syndrome. These results suggest that hereditary cerebral hemorrhage with amyloidosis of Dutch origin is pathogenetically related to Alzheimer disease and support the concept that the initial amyloid deposition in this disorder occurs in the vessel walls before damaging the brain parenchyma. Thus, deposition of beta-protein in brain tissue seems to be related to a spectrum of diseases involving vascular syndromes, progressive dementia, or both.

Full text

PDF
5992

Images in this article

5992Image
on p.5992
5993Image
on p.5993

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blessed G., Tomlinson B. E., Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968 Jul;114(512):797–811. doi: 10.1192/bjp.114.512.797. [DOI] [PubMed] [Google Scholar]
  2. Burger P. C., Vogel F. S. The development of the pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome. Am J Pathol. 1973 Nov;73(2):457–476. [PMC free article] [PubMed] [Google Scholar]
  3. Castaño E. M., Ghiso J., Prelli F., Gorevic P. D., Migheli A., Frangione B. In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease beta-protein. Biochem Biophys Res Commun. 1986 Dec 15;141(2):782–789. doi: 10.1016/s0006-291x(86)80241-8. [DOI] [PubMed] [Google Scholar]
  4. Cohen D. H., Feiner H., Jensson O., Frangione B. Amyloid fibril in hereditary cerebral hemorrhage with amyloidosis (HCHWA) is related to the gastroentero-pancreatic neuroendocrine protein, gamma trace. J Exp Med. 1983 Aug 1;158(2):623–628. doi: 10.1084/jem.158.2.623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cosgrove G. R., Leblanc R., Meagher-Villemure K., Ethier R. Cerebral amyloid angiopathy. Neurology. 1985 May;35(5):625–631. doi: 10.1212/wnl.35.5.625. [DOI] [PubMed] [Google Scholar]
  6. Esiri M. M., Wilcock G. K. Cerebral amyloid angiopathy in dementia and old age. J Neurol Neurosurg Psychiatry. 1986 Nov;49(11):1221–1226. doi: 10.1136/jnnp.49.11.1221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ghiso J., Jensson O., Frangione B. Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C). Proc Natl Acad Sci U S A. 1986 May;83(9):2974–2978. doi: 10.1073/pnas.83.9.2974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ghiso J., Pons-Estel B., Frangione B. Hereditary cerebral amyloid angiopathy: the amyloid fibrils contain a protein which is a variant of cystatin C, an inhibitor of lysosomal cysteine proteases. Biochem Biophys Res Commun. 1986 Apr 29;136(2):548–554. doi: 10.1016/0006-291x(86)90475-4. [DOI] [PubMed] [Google Scholar]
  9. Gilles C., Brucher J. M., Khoubesserian P., Vanderhaeghen J. J. Cerebral amyloid angiopathy as a cause of multiple intracerebral hemorrhages. Neurology. 1984 Jun;34(6):730–735. doi: 10.1212/wnl.34.6.730. [DOI] [PubMed] [Google Scholar]
  10. Glenner G. G., Wong C. W. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun. 1984 Aug 16;122(3):1131–1135. doi: 10.1016/0006-291x(84)91209-9. [DOI] [PubMed] [Google Scholar]
  11. Glenner G. G., Wong C. W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984 May 16;120(3):885–890. doi: 10.1016/s0006-291x(84)80190-4. [DOI] [PubMed] [Google Scholar]
  12. Goldgaber D., Lerman M. I., McBride O. W., Saffiotti U., Gajdusek D. C. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science. 1987 Feb 20;235(4791):877–880. doi: 10.1126/science.3810169. [DOI] [PubMed] [Google Scholar]
  13. Gorevic P. D., Goñi F., Pons-Estel B., Alvarez F., Peress N. S., Frangione B. Isolation and partial characterization of neurofibrillary tangles and amyloid plaque core in Alzheimer's disease: immunohistological studies. J Neuropathol Exp Neurol. 1986 Nov;45(6):647–664. doi: 10.1097/00005072-198611000-00004. [DOI] [PubMed] [Google Scholar]
  14. Gorevic P. D., Munoz P. C., Casey T. T., DiRaimondo C. R., Stone W. J., Prelli F. C., Rodrigues M. M., Poulik M. D., Frangione B. Polymerization of intact beta 2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis. Proc Natl Acad Sci U S A. 1986 Oct;83(20):7908–7912. doi: 10.1073/pnas.83.20.7908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Grubb A., Jensson O., Gudmundsson G., Arnason A., Löfberg H., Malm J. Abnormal metabolism of gamma-trace alkaline microprotein. The basic defect in hereditary cerebral hemorrhage with amyloidosis. N Engl J Med. 1984 Dec 13;311(24):1547–1549. doi: 10.1056/NEJM198412133112406. [DOI] [PubMed] [Google Scholar]
  16. Gudmundsson G., Hallgrímsson J., Jónasson T. A., Bjarnason O. Hereditary cerebral haemorrhage with amyloidosis. Brain. 1972;95(2):387–404. doi: 10.1093/brain/95.2.387. [DOI] [PubMed] [Google Scholar]
  17. Kang J., Lemaire H. G., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschik K. H., Multhaup G., Beyreuther K., Müller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 1987 Feb 19;325(6106):733–736. doi: 10.1038/325733a0. [DOI] [PubMed] [Google Scholar]
  18. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  19. Lee S. S., Stemmermann G. N. Congophilic angiopathy and cerebral hemorrhage. Arch Pathol Lab Med. 1978 Jun;102(6):317–321. [PubMed] [Google Scholar]
  20. Luyendijk W., Bots G. T., Vegter-van der Vlis M., Went L. N. Familiaire hersenbloedingen als gevolg van cerebrale amyloïde angiopathie. Ned Tijdschr Geneeskd. 1986 Oct 25;130(43):1935–1940. [PubMed] [Google Scholar]
  21. Mandybur T. I. The incidence of cerebral amyloid angiopathy in Alzheimer's disease. Neurology. 1975 Feb;25(2):120–126. doi: 10.1212/wnl.25.2.120. [DOI] [PubMed] [Google Scholar]
  22. Masters C. L., Multhaup G., Simms G., Pottgiesser J., Martins R. N., Beyreuther K. Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J. 1985 Nov;4(11):2757–2763. doi: 10.1002/j.1460-2075.1985.tb04000.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A. 1985 Jun;82(12):4245–4249. doi: 10.1073/pnas.82.12.4245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. NEUMANN M. A. Combined amyloid vascular changes and argyrophilic plaques in the central nervous system. J Neuropathol Exp Neurol. 1960 Jul;19:370–382. doi: 10.1097/00005072-196007000-00005. [DOI] [PubMed] [Google Scholar]
  25. Okazaki H., Reagan T. J., Campbell R. J. Clinicopathologic studies of primary cerebral amyloid angiopathy. Mayo Clin Proc. 1979 Jan;54(1):22–31. [PubMed] [Google Scholar]
  26. Pras M., Franklin E. C., Shibolet S., Frangione B. Amyloidosis associated with renal cell carcinoma of the AA type. Am J Med. 1982 Sep;73(3):426–428. doi: 10.1016/0002-9343(82)90747-1. [DOI] [PubMed] [Google Scholar]
  27. Pras M., Schubert M., Zucker-Franklin D., Rimon A., Franklin E. C. The characterization of soluble amyloid prepared in water. J Clin Invest. 1968 Apr;47(4):924–933. doi: 10.1172/JCI105784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Stam F. C., Wigboldus J. M., Smeulders A. W. Age incidence of senile brain amyloidosis. Pathol Res Pract. 1986 Oct;181(5):558–562. doi: 10.1016/S0344-0338(86)80149-2. [DOI] [PubMed] [Google Scholar]
  29. Tanzi R. E., Gusella J. F., Watkins P. C., Bruns G. A., St George-Hyslop P., Van Keuren M. L., Patterson D., Pagan S., Kurnit D. M., Neve R. L. Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science. 1987 Feb 20;235(4791):880–884. doi: 10.1126/science.2949367. [DOI] [PubMed] [Google Scholar]
  30. Wattendorff A. R., Bots G. T., Went L. N., Endtz L. J. Familial cerebral amyloid angiopathy presenting as recurrent cerebral haemorrhage. J Neurol Sci. 1982 Aug;55(2):121–135. doi: 10.1016/0022-510x(82)90094-6. [DOI] [PubMed] [Google Scholar]
  31. Wisniewski K. E., Wisniewski H. M., Wen G. Y. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol. 1985 Mar;17(3):278–282. doi: 10.1002/ana.410170310. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES